Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)
Clinical trial NCT04956289 · COMPLETED
Trial details
- NCT number
- NCT04956289
- Sponsor
- NS Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-06-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.